Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook
January 25, 2023 7:30 AM ESTFourth-quarter sales of $10.1 billion; full-year 2022 sales of $43.7 billionFull-year 2022 sales growth of 1.3 percent; organic sales growth of 6.4 percentFull-year 2022 GAAP diluted EPS of $3.91; adjusted diluted EPS of $5.34Continues to strengthen portfolio with steady cadence of new product approvals
ABBOTT PARK, Ill., Jan. 25, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2022.
Fourth-quarter sales of $10.1 billion, which were negatively impacted by an expected year-over-year decline in COVID-19 testing-related sales, decreased 12.0 percent on a reported basis... More